Hope Care Raises €6 Million in Series A Funding
Hope Care, a digital health company based in Óbidos, Portugal, has successfully raised €6 million in its Series A funding round. The round was led by Iberis Capital, with participation from VDM Capital and Buenavista Equity Partners. The company specializes in developing regulated technology that enables healthcare providers to monitor patients remotely, particularly focusing on managing chronic conditions efficiently.
Leadership Perspective
José Carvalho, Founder and CEO of Hope Care, expressed that this funding marks a significant milestone for the company. "After more than a decade working with healthcare institutions, we have built a regulated platform that delivers measurable outcomes for patients, healthcare professionals, and healthcare systems," Carvalho said. "With the support of our investors, we are now well-positioned to accelerate our European expansion and bring this model of care to more healthcare organisations."
Investor Insights
João Henriques, Partner at Iberis Capital, noted the growing challenges faced by European health systems in managing chronic diseases. "Hope Care is one of the few companies that pairs proven clinical evidence with the regulatory maturity to operate inside public health systems at scale," Henriques commented. "This is a model we are proud to help scale across Europe, since it helps clinicians improve outcomes for patients and ultimately the sustainability of care."
Strategic Use of Funds
The €6 million raised will be directed towards expanding Hope Care's remote patient monitoring services across Europe. This strategic move aims to enhance the company's ability to support healthcare systems in managing chronic conditions more proactively, thereby improving patient outcomes and alleviating the burden on healthcare providers.
Hope Care's innovative approach and the recent funding boost position it well to address the increasing demand for effective health management solutions across Europe.